Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study shows benefits of therapy dogs for fibromyalgia
The study found that people living with fibromyalgia experienced a more positive emotional state after a single session with a therapy dog.
Researchers investigate the emotional impact of animal-assisted therapy on this chronic condition. 

The benefits of animal-assisted therapy (AAT) have been highlighted once again in a study investigating the emotional impact of therapy dogs on people with fibromyalgia.

AAT, a term used when a clinician provides therapy with the assistance of an animal, has been used by the NHS for mental and physical illness, including dementia, depression, schizophrenia and addiction. In a newly-published study, researchers at Purina and Mayo Clinic investigated the impact of AAT on patients with fibromyalgia, a chronic condition that causes pain all over the body.

The team found that people living with fibromyalgia experienced a more positive emotional state after a single session with a therapy dog. Patients saw their oxytocin levels increase significantly, while their heart rates decreased. They also reported less negative and more positive emotions.

Lead Mayo Clinic researcher Professor Arya Mohabbat said: "The 'Better Together' study showed therapy animals could be an evidence-based treatment option, and healthcare professionals should strongly consider utilising animal-assisted activity in the care of their patients with fibromyalgia.”

Interestingly, the study also investigated the impact of the therapy sessions on the emotional state of the dogs. Scientists found that the dogs did not show any sign of stress during the animal-assisted session, and may have been in a more relaxed state at the end of the session.

Researchers also report that, for most parameters, there were no changes in the dogs, signalling contentment. For those that did change, however, they pointed to a more positive emotional and physiological state, such as a significantly lower heart rate.

Professor François Martin, the lead Purina scientist on the project, explained: “We need to expand our understanding of how animal-assisted activity impacts therapy dog’s wellbeing, and this study with 19 dogs of various breeds provided solid evidence that animal-assisted activity done in the right condition does not have negative impacts on well-trained therapy dogs.

“This only encourages us to do more research to continue to demonstrate the power of the human-animal bond on people while ensuring assistance animals also experience positive wellness as a result of their work.”

Currently, there is no cure for fibromyalgia, and many individuals seek non-conventional treatments in search of relief. The authors of the study conclude that a 20-minute therapy dog visit could significantly and positively impact the physical and mental health of patients with fibromyalgia.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.